Y-mAbs Announces Update on DANYELZA® (naxitamab-gqgk) at ESMO
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
Day: December 9, 2020
SEngine Precision Medicine Presents Data Summarizing Predictive Value of PARIS® Test in Breast Cancer Patients at 2020 San Antonio Breast Cancer Symposium
SEATTLE, Dec. 09, 2020 (GLOBE NEWSWIRE) -- SEngine Precision Medicine, a precision oncology company revolutionizing cancer therapies by pre-testing drugs...
Ellume’s COVID-19 Home Test shows 96% accuracy in multi-site US clinical study
The Ellume COVID-19 Home Test App The Ellume COVID-19 Home Test connects directly to users’ smartphone, providing for step-by-step instructions...
PDS Biotechnology Appoints Seth Van Voorhees as Chief Financial Officer
FLORHAM PARK, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel...
Athenex Presents Updated Phase 3 Data on Survival and Tolerability Associated with Oral Paclitaxel and Encequidar in Patients with Metastatic Breast Cancer
Data presented at SABCS indicates benefits of oral paclitaxel and encequidar (oral paclitaxel) versus IV paclitaxel (IVP) on Progression-Free Survival...
Alimera Sciences Announces Launch of ILUVIEN® in the Netherlands
ILUVIEN has been launched for both Diabetic Macular Edema and Non-Infectious Posterior Uveitis IndicationsATLANTA, Dec. 09, 2020 (GLOBE NEWSWIRE) --...
Artelo Biosciences Files Patent Application for New Formulation of ART27.13
Expanding the patent estate for the lead clinical program to treat cancer anorexiaLA JOLLA, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE)...
Predictive Oncology Sends Letter to Shareholders Regarding Special Meeting to be Reconvened on December 30, 2020
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence...
Daxor Corporation to Present at the 13th Annual LD Micro Main Event 2020
NEW YORK, NY, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical...
Biomerica’s InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment
Patient enrollment completion anticipated by the end of April 2021InFoods® Diagnostic-Guided Therapy is designed to address the $30 billion market...
Applied Therapeutics Announces Launch of Galactosemia Awareness and Education Initiative
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...
Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors
GAITHERSBURG, Md., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for...
Celldex Doses First Patient in Phase 1b Study of CDX-0159 in Chronic Inducible Urticaria
HAMPTON, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that the first patient has been...
Biotricity to Present at the 13th Annual LD Micro Main Event and Host Virtual One-on-One Meetings with Investors
REDWOOD CITY, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company,...
Delcath Systems Announces Pricing of Public Offering of Common Stock
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the...
EDAP Announces Final U.S. 2021 Reimbursement Rules for High Intensity Focused Ultrasound (HIFU)
Final rules establish, for the first time, a Category 1 CPT code and reimbursement to physicians performing ablation of...
Protech Home Medical Announces New Independent Board Member
Dr. Kevin A. Carter Appointed to Board of DirectorsCINCINNATI, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Protech Home Medical Corp. (“Protech”...
ImmunoGenesis: Acquisition Strengthens “Cold” Tumor Targeting Pipeline
ImmunoGenesis acquires rights to evofosfamide; Phase 2 clinical testing in combination with checkpoint blockade is planned for 2021.Evofosfamide is the only...
Intra-Cellular Therapies Highlights Lumateperone Presentations at the 59th Annual Meeting of the American College of Neuropsychopharmacology
Presentations highlight lumateperone’s broad antidepressant effects in patients with bipolar disorder and in patients with schizophrenia with co-morbid depression NEW...
ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors
Increases Size of Facility and Extends Interest-Only Period Enabling ADMA to Reach Profitability Prior to Maturity Demonstrates Perceptive’s Commitment and...